Cell Host & Microbe 20, October 2016
Kai Dallmeier, Johan Neyts
Kai Dallmeier and Johan Neyts from the Rega Institute for Medical Research, Department of Microbiology & Immunology, University of Leuven, Leuven, Belgium look at the in vitro screens conducted by Barrows et al. (2016) and Xu et al. (2016) with the goal of identifying FDA-licensed drugs and drug-like small molecules that could potentially be repurposed to prevent and treat ZIKV infections.